Journal
CLINICAL AND EXPERIMENTAL OTORHINOLARYNGOLOGY
Volume 3, Issue 1, Pages 13-17Publisher
KOREAN SOC OTORHINOLARYNGOL
DOI: 10.3342/ceo.2010.3.1.13
Keywords
Pulmonary surfactant; Nebulization; Otitis media with effusion
Categories
Funding
- Korea government (MEST) through the Research Center for Resistant Cells [R13-2003-009]
- Chonnam National University Hospital Research Institute of Clinical Medicine [CRI09084-1]
Ask authors/readers for more resources
Objectives. In this study, we evaluated the efficacy of nebulized bovine pulmonary surfactant on experimentally induced otitis media with effusion (OME) in guinea pigs. Methods. Twenty guinea pigs were divided into three groups. Four untreated animals served as normal controls. Experimental OME was established in both ears of the remaining 16 animals by a transbullar injection of 10 mu L of Pseudomonas aeruginosa lipopolysaccharide in saline. Thereafter, the guinea pigs received nebulized phosphate buffered saline (n=8) or nebulized bovine pulmonary surfactant (n=8). Nebulization was given daily for 7 days. On day 8, all the animals' passive opening pressure (POP) of the Eustachian tube was measured and histopathological observations of the bulla were made by light microscopy. Results. Nebulized bovine pulmonary surfactant significantly reduced the POP compared to that of saline nebulization. The bovine pulmonary surfactant improved the tubal patency and produced less histopathologcally-evident edematous bullar mucosa. Conclusion. Nebulization of bovine pulmonary surfactant plays an important role in treating otitis media with effusion in guinea pigs. Our results suggest that the chosen nebulized bovine pulmonary surfactant can be of good clinical benefit for treating OME in the future.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available